Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Entera Bio Ltd. - Ordinary Shares (NQ:ENTX)

1.450 +0.120 (+9.02%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Entera Bio Ltd. - Ordinary Shares

< Previous 1 2 3 Next >
News headline image
Why Compass Shares Are Trading Higher By Over 56%? Here Are 63 Stocks Moving In Friday's Mid-Day Session ↗
Gainers Snail, Inc. (NASDAQ: SNAL) shares jumped 74.9% to $3.9350 after the company announced a $5 million share repurchase program. 
Via Benzinga
News headline image
Why Missfresh Shares Are Trading Lower; Here Are 30 Stocks Moving Premarket ↗
Gainers M-tron Industries, Inc. (NASDAQ: MPTI) rose 57.9% to $24.00 in pre-market trading after surging 10% on Friday. M-tron Industries completed its earlier announced separation from The LGL Group,... 
Via Benzinga
News headline image
Entera Bio: Q2 Earnings Insights ↗
  Entera Bio (NASDAQ:ENTX) reported its Q2 earnings results on Thursday, August 11, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Entera Bio Outlines Pivotal Osteoporosis Trial, Names New CEO ↗
 
Via Benzinga
News headline image
121 Stocks That Hit Their 52-Week Low ↗
New Equities that Broke Through 52-Week Lows Friday Morning During Friday's morning session, 121 stocks hit new 52-week lows. 
Via Benzinga
News headline image
Recap: Entera Bio Q1 Earnings ↗
Entera Bio (NASDAQ:ENTX) reported its Q1 earnings results on Thursday, May 12, 2022 at 08:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Recap: Entera Bio Q4 Earnings ↗
Entera Bio (NASDAQ:ENTX) reported its Q4 earnings results on Tuesday, March 8, 2022 at 06:30 AM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2022 ↗
Upgrades 
Via Benzinga
News headline image
$5.1 Million Bet On Tabula Rasa HealthCare? 3 Penny Stocks Insiders Are Buying ↗
US crude oil futures traded higher by around 1% on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern... 
Via Benzinga
News headline image
This Healthcare Stock Jumped 110%; Here Are 64 Biggest Movers From Yesterday ↗
 Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) shares climbed 264% to close at $18.20 on Thursday. The company offered shares at an expected price of $5.00 per share with an insider lock-up period... 
Via Benzinga
News headline image
Recap of Monday's Biotech Catalysts - End of the Day Summary ↗
Abbvie (NYSE: ABBV) has submitted a marketing authorization application (MAA) to the European Medicines Agency (EMA) for atogepant for the prophylaxis of migraine in adult patients who have at least... 
Via Benzinga
News headline image
82 Biggest Movers From Yesterday ↗
Gainers Comera Life Sciences Holdings, Inc. (NASDAQ: CMRA) gained 126.5% to settle at $2.65 on Tuesday. 
Via Benzinga
News headline image
41 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Revlon, Inc. (NYSE: REV) rose 125.5% to $2.6499. Revlon’s stock dropped sharply on Monday after the company is reportedly expected to file for bankruptcy. 
Via Benzinga
News headline image
Follow the Insiders and Buy the Dip in These 3 Stocks ↗
These three biotech companies have all had insiders buying shares recently. That's a good sign for the future of their treatments. 
Via InvestorPlace
News headline image
Recession Fears are Creating a Golden Opportunity for Biotech Stocks ↗
Biotech stocks are hard for novice investors to successfully profit from, but it's worth your time to learn the techniques now. 
Via InvestorPlace
News headline image
4 Penny Stocks Insiders Are Buying: Crexendo, Performant Financial And More ↗
Silver prices surged above $24 per troy ounce for the first time in more than two months and investors also focused on some notable insider... 
Via Benzinga
News headline image
5 Penny Stocks Insiders Are Buying ↗
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders intereste... 
Via Benzinga
News headline image
Entera Bio's Formulated Human Parathyroid Hormone Shows Encouraging BMD Data ↗
Entera Bio Ltd (NASDAQ: ENTX) has presented the 6-month bone mineral density (BMD) data from its Phase 2 trial of EB613, an oral formulation of human parathyroid... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks... 
Via Benzinga
News headline image
Neurodegenerative Disease And Cancer Stocks Among Top Biotech Gainers In 2021 ↗
Biotech stocks underperformed the broader market in the first half of 2021, with the iShares Nasdaq Biotechnology ETF IBB advancing about 8% year-to-date compared to the roughly 14% gain for the S&P... 
Via Talk Markets
Topics Stocks
News headline image
Earnings Scheduled For August 16, 2021 ↗
Companies Reporting Before The Bell • Entera Bio (NASDAQ:ENTX) is likely to report earnings for its second quarter. • Data Storage (NASDAQ:DTST) is expected to... 
Via Benzinga
News headline image
Neurodegenerative Disease, Cancer Stocks Among Top Biotech Gainers In 2021 ↗
Biotech stocks underperformed the broader market in the first half of 2021, with the iShares Nasdaq Biotechnology ETF (NASDAQ: IBB) advancing about 8% year-to-date ... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Lilly Spikes On Alzheimer's Drug Regulatory Filing Plan, Applied Genetics, Arcus Issue Data Readouts, Adcom Test Awaits Incyte, Monte Rosa Prices IPO ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 23) AngioDynamics, Inc. (NASDAQ... 
Via Benzinga
News headline image
45 Biggest Movers From Yesterday ↗
Gainers Entera Bio Ltd. (NASDAQ: ENTX) shares surged 44.8% to close at $6.50 on Wednesday after the company reported topline Phase 2 bone mineral density data for EB613. First... 
Via Benzinga
News headline image
Where Might Entera Bio Stock End Up After Rallying Wednesday ↗
Entera Bio Ltd (NASDAQ: ENTX) shares rallied higher Wednesday after the company announced it saw positive results from its final six-month bone mineral density results from... 
Via Benzinga
News headline image
ENTX Stock: The Huge FDA News Sending Entera Bio Soaring ↗
Today, investors in ENTX stock are seeing gains of approximately 40% as the company announced results from one of its clinical trials. 
Via InvestorPlace
News headline image
Mid-Afternoon Market Update: Patterson Companies Drops On Earnings Miss; Entera Bio Shares Gain ↗
Toward the end of trading Wednesday, the Dow traded down 0.08% to 33,918.98 while the NASDAQ rose 0.16% to 14,276.41. The S&P also rose, gaining 0.05% to 4,248.47. The U.S.... 
Via Benzinga
Topics Stocks
News headline image
Nasdaq Notches Intraday High, SPX Eyes Third-Straight Win ↗
The Dow Jones Industrial Average is modestly lower this afternoon, walking back this morning's gains to register a 19-point drop. 
Via Talk Markets
Topics Stocks
News headline image
Why Entera Bio, Orphazyme, Bellerophon Are Moving Today ↗
Entera Bio Ltd. (NASDAQ: ENTX), Orphazyme A/S (NASDAQ: ORPH) and Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) are among the biggest biopharma movers Wednesday. Entera Bio Climbs... 
Via Benzinga
News headline image
Why Entera Bio Shares Are Skyrocketing Today ↗
Entera Bio Ltd (NASDAQ: ENTX) shares are trading higher by 47.66% at $6.63 Wednesday after the company announced the topline Phase 2 clinical trial of EB613 met its primary... 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.